NIH-funded research NIH-funded research

How the liver's ketone production affects muscle loss and recovery in pancreatic cancer

Official title: Elucidating the role of hepatic ketogenesis in pancreatic cancer cachexia and recovery

Funded at Rosalind Franklin Univ of Medicine & Sci · NIH-11457142 · Data updated 2026-11-12

This project looks at whether helping the liver make ketones can prevent muscle wasting and aid recovery for people with pancreatic cancer.

More Pancreatic Cancer research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionRosalind Franklin Univ of Medicine & Sci
NIH-funded
Lab location1 site (North Chicago, United States)
Project startFebruary 1, 2024
Project endFebruary 28, 2029
Funding year2026
Award (this year)$248,999
NIH project number4R00CA286709-03
Project IDNIH-11457142 on NIH RePORTER

Who could benefit from this research

Could help

People with pancreatic ductal adenocarcinoma who are experiencing or at risk for cachexia (loss of skeletal muscle mass) would be the ideal candidates for this line of research.

Less likely to help

People without pancreatic cancer or those whose muscle loss is driven by causes unrelated to liver ketogenesis or STAT3 signaling are unlikely to benefit from these specific findings.

What this research studies

You will hear about work aiming to explain why many people with pancreatic cancer lose muscle despite eating. Researchers focus on how inflammation and the liver protein STAT3 stop the liver from switching to ketone production during times of low nutrition. They use lab models, genetic tools, and molecular assays (including ATAC-seq) to find the signals that block liver fat use. The team plans to test whether restoring liver ketogenesis can stop or reverse muscle loss and improve recovery after cancer.

Why it matters

Potential benefit: If successful, this could lead to new treatments that prevent or reverse cancer-related muscle wasting, improving strength, quality of life, and eligibility for cancer therapies.

How similar studies have gone: Early animal studies from this group show restoring liver ketogenesis can prevent cachexia in mice, but translating this approach to human patients remains largely untested.

Where this research is happening

  • Rosalind Franklin Univ of Medicine & Sci
    North Chicago, United States
    Active

Researchers

  • Principal investigator: Arneson-Wissink, Paige C — Rosalind Franklin Univ of Medicine & Sci
  • Study coordinator: Arneson-Wissink, Paige C

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.